Contribute Try STAT+ Today

Hello, everyone, and how are you today? We are doing just fine, thank you, especially now that the short person has left for the local schoolhouse and the official mascots are officially snoozing. All of which is to say that the Pharmalot campus has quieted down just enough for us to focus on the task at hand, which is foraging for items of interest. Of course, a cup or more of stimulation can be useful, as well. Meanwhile, here are some tidbits to help you on your own journey. Hope your day is simply smashing and do keep us in mind when something interesting arises …

Amazon (AMZN) has shelved plans to sell and distribute pharmaceutical products through Amazon Business, its marketplace for business customers, CNBC tells us.The biggest challenges include complexities around selling in bulk to large hospitals and building a logistics network to handle delivery, but Amazon could still get into pharmaceuticals another way because it still has multiple teams working on health care. And it is worth noting that this development does not address the retail pharmacy business.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.